What we do
The ALBORADA Drug Discovery Institute sits within the Cambridge Biomedical Campus, one of the largest concentrations of medical research expertise in the world.
Our drug discovery expertise will bridge the gap between the deep disease understanding of academia and the drug development capabilities within the pharmaceutical/biotechnology industry and clinical centres of excellence. We intend to engage closely with our industrial and clinical partners during the discovery process, to ensure successful candidates continue through the drug discovery pipeline.
We are looking to forge collaborations with academic groups and with industry as we seek out new targets for neurodegenerative diseases. Find out more about how we can work with you to develop novel therapeutics by acting as a conduit between your research and the clinic.
The ALBORADA Drug Discovery Institute is part of a wider Drug Discovery Alliance, funded by the charity Alzheimer’s Research UK and launched in 2014. The Cambridge Drug Discovery Institute will work alongside Institutes at the University of Oxford and University College London to create one of the largest coordinated efforts to drive academic drug discovery into neurodegenerative diseases. If you would like more information about the Alliance, its operation or governance, please contact the Research team at Alzheimer’s Research UK.